男友太凶猛1v1高h,大地资源在线资源免费观看 ,人妻少妇精品视频二区,极度sm残忍bdsm变态

Global EditionASIA 中文雙語Fran?ais
China
Home / China / The fight against novel coronavirus

Ministry working with researchers on 16 emergency coronavirus projects

By ZHANG ZHIHAO | chinadaily.com.cn | Updated: 2020-02-04 17:54
Share
Share - WeChat

The Ministry of Science and Technology is collaborating with 12 different government agencies and research institutions in five major research areas to tackle the novel coronavirus: investigating its origin and creating drugs, vaccines, animal test models and viral test kits.

Since the outbreak, the ministry has kept a close eye on the situation and launched 16 emergency research projects. At the same time, it has examined existing research projects to find solutions and ideas to combat the virus, Sun Yanrong, deputy director of the ministry's biology center, told a press briefing on Tuesday.

"We have organically combined scientific research with clinical needs and prevention measures to provide effective products and technologies for tackling the epidemic," she said, adding scientists had made considerable progress in the five major research areas.

For example, Chinese scientists swiftly isolated the viral strains and sequenced the virus' whole genome, she said. They are also working on new viral testing kits using immunological technologies to supplement the current kits, which are based on molecular biology.

In terms of medicine, Sun said scientists had selected many pre-existing drugs that may have the potential to inhibit the virus during in vitro experiments, and they are busy testing their safety and potency on lab animals and in clinical trials.

"We will keep conducting systematic research and enhance our international cooperation," she said.

The experimental drug Remdesivir, which had shown exceptional therapeutic capability against the novel coronavirus in one United States patient, would arrive in China for clinical trial on Tuesday afternoon, Sun added, debunking a rumor from Monday that claimed more than 200 patients from Wuhan, Hubei province, had received the medication and their conditions had immediately improved.

On Sunday, Beijing's China-Japan Friendship Hospital said it would begin clinical trials on 270 moderately ill patients infected with the virus in Wuhan using Remdesivir, which was originally developed as an Ebola cure.

The trial has been approved and will run from Monday to April 27, the National Medical Products Administration's Center for Drug Evaluation said.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 东乡族自治县| 赞皇县| 墨竹工卡县| 开鲁县| 陇川县| 来凤县| 汝州市| 清徐县| 永定县| 凌源市| 龙南县| 浦北县| 白银市| 黄山市| 恩平市| 青神县| 延川县| 安新县| 蒙阴县| 镇安县| 马边| 万荣县| 镇沅| 休宁县| 奉贤区| 台山市| 平和县| 滕州市| 莱州市| 巢湖市| 宜城市| 英山县| 海城市| 广平县| 务川| 思南县| 丰原市| 读书| 庆城县| 营山县| 西平县|